tirzepatide surmount 3 Diabetes Dialogue: SURMOUNT-3 and -4 Inform Use of in Obesity Tirzepatide for Obesity Treatment and

Gut microbiota and its role in neuropsychiatric disorders

Peptides and exosomes can be administered in stable forms, including injections, sprays, or topical applications

Patients with genetic variants predicting high GLP-1 receptor sensitivity may benefit from oral semaglutide ($289/mo) instead, which bypasses the stomach initially and may produce fewer acid-related side effects

How to Get the Best Results from Your Treatment GLP-1 medications are a powerful tool for weight loss, but they arent a standalone solution

FDA-Approved Uses As of 2026, tirzepatide (Zepbound) carries two FDA-approved indications: Chronic weight management approved November 2023 for adults with obesity (BMI 30) or overweight (BMI 27) with at least one weight-related comorbidity such as high blood pressure, type 2 diabetes, or high cholesterol